Skip to content

Amgen beats in 1Q; guidance in line

April 27, 2017

Amgen (NASDAQ: AMGN) reported Q1 EPS of $3.15, $0.15 better than the analyst estimate of $3.00. Revenue for the quarter came in at $5.5 billion versus the consensus estimate of $5.61 billion.

GUIDANCE:

Amgen sees FY2017 EPS of $12.00-$12.60, versus the consensus of $12.33. Amgen sees FY2017 revenue of $22.3-23.1 billion, versus the consensus of $23 billion.

http://bit.ly/2qb3ULx

Advertisements

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: